Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

John Wiley & Sons (WLY) Cash & Equivalents (2016 - 2026)

John Wiley & Sons (WLY) has disclosed Cash & Equivalents for 18 consecutive years, with $95.1 million as the latest value for Q1 2026.

  • Quarterly Cash & Equivalents fell 8.99% to $95.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $95.1 million through Jan 2026, down 8.99% year-over-year, with the annual reading at $85.9 million for FY2025, 3.16% up from the prior year.
  • Cash & Equivalents for Q1 2026 was $95.1 million at John Wiley & Sons, up from $67.4 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $126.4 million in Q1 2023, with the low at $67.4 million in Q4 2025.
  • Average Cash & Equivalents over 5 years is $93.7 million, with a median of $93.1 million recorded in 2024.
  • The sharpest move saw Cash & Equivalents grew 25.92% in 2022, then fell 29.73% in 2023.
  • Over 5 years, Cash & Equivalents stood at $118.4 million in 2022, then decreased by 29.73% to $83.2 million in 2023, then dropped by 9.23% to $75.5 million in 2024, then decreased by 10.77% to $67.4 million in 2025, then surged by 41.11% to $95.1 million in 2026.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $95.1 million, $67.4 million, and $81.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.